Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE Small Cap

228.50p
   
  • Change Today:
      8.50p
  • 52 Week High: 470.00
  • 52 Week Low: 166.80
  • Currency: UK Pounds
  • Shares Issued: 100.00m
  • Volume: 257,823
  • Market Cap: £228.50m
  • RiskGrade: 125

Deal with Barclays    Trade now with Barclays Stockbrokers

Geographical - by origin

  31-Dec-2031-Dec-1931-Dec-1831-Dec-1031-Dec-09
Revenue
Europe52.8260%46.6073%41.5462%10.3593%18.9999%
Rest of World34.9140%17.4627%25.2438%n/an/an/an/a
USAn/an/an/an/an/an/a0.817%0.131%
Total 87.73100% 64.06100% 66.78100% 11.15100% 19.12100% 
 
Profit Before Tax
Unanalysed(6.57)100%(20.89)100%5.01100%(11.80)100%(5.09)100%
Total (6.57)100% (20.89)100% 5.01100% (11.80)100% (5.09)100% 

Geographical - by origin (turnover)

Product breakdown (turnover)

Product breakdown

  31-Dec-2031-Dec-1931-Dec-1831-Dec-1031-Dec-09
Revenue
Bioprocessing / Commercial developmentn/an/an/an/a40.5061%n/an/an/an/a
Biotechnology research and developmentn/an/an/an/an/an/a11.15100%19.12100%
License fees & incentivesn/an/an/an/a26.2739%n/an/an/an/a
Platform87.1299%51.0080%n/an/an/an/an/an/a
Product0.611%13.0620%n/an/an/an/an/an/a
Total 87.73100% 64.06100% 66.78100% 11.15100% 19.12100% 
 
Profit Before Tax
Biotechnology research and developmentn/an/an/an/an/an/a(11.80)100%(5.09)100%
Unanalysed(6.57)n/a(20.89)n/a5.01n/an/an/an/an/a
Total (6.57)n/a (20.89)n/a 5.01n/a (11.80)100% (5.09)100% 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: Forecast figures based on normalised accounts.

 

Top of Page